Point Of Return
Growth, deep value, long/short equity, momentum

Rise Of The Machines: Why A Robot May Be Your Next Surgeon, And How You Can Benefit

**UPDATE 6/17/2014: Yesterday morning Titan announced it successfully completed animal tissue studies on May 30, 2014, performing a full cholecystectomy (gallbladder removal) procedure using the SPORT™ surgical system alpha commercial prototype for the required surgical tasks (including grasping, dissecting, mono-polar cautery and suturing). The procedure has been "extensively validated". Aside from the obvious that the animal tissue testing has been completed, the implications are two-fold: (1) the technology is successful and has performed as expected thus far in the process; (2) management has achieved another milestone and continues to meet its goals.

TITXF reached an intraday high of $1.80, and closed up 3.6%. Yesterday's news is important as investors have failed to recognize the disruptive potential and true value...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details